ATE348116T1 - Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen - Google Patents

Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen

Info

Publication number
ATE348116T1
ATE348116T1 AT00991953T AT00991953T ATE348116T1 AT E348116 T1 ATE348116 T1 AT E348116T1 AT 00991953 T AT00991953 T AT 00991953T AT 00991953 T AT00991953 T AT 00991953T AT E348116 T1 ATE348116 T1 AT E348116T1
Authority
AT
Austria
Prior art keywords
cyclodextrin
beta
mixtures
methyl esters
related compounds
Prior art date
Application number
AT00991953T
Other languages
English (en)
Inventor
Freres Roquette
Original Assignee
Freres Roquette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freres Roquette filed Critical Freres Roquette
Application granted granted Critical
Publication of ATE348116T1 publication Critical patent/ATE348116T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00991953T 1999-11-12 2000-11-09 Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen ATE348116T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16494999P 1999-11-12 1999-11-12

Publications (1)

Publication Number Publication Date
ATE348116T1 true ATE348116T1 (de) 2007-01-15

Family

ID=22596786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00991953T ATE348116T1 (de) 1999-11-12 2000-11-09 Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen

Country Status (10)

Country Link
US (1) US6602860B1 (de)
EP (1) EP1272531B8 (de)
JP (1) JP2003514925A (de)
CN (1) CN1303107C (de)
AT (1) ATE348116T1 (de)
AU (1) AU3643301A (de)
CA (1) CA2391008C (de)
DE (1) DE60032388T2 (de)
MX (1) MXPA02004743A (de)
WO (1) WO2001036490A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1462512B1 (de) * 2003-03-24 2007-08-01 The Procter & Gamble Company Zusammensetzungen enthaltend Cyclodextrinkomplexe und mindestens ein Waschmitteladditiv
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN102458114A (zh) 2009-05-29 2012-05-16 锡德克斯药物公司 包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
FR3014694B1 (fr) 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
FR3042501B1 (fr) 2015-10-16 2017-11-03 Roquette Freres Nouvelles cyclodextrines methylees et leurs procedes de preparation
WO2021180742A1 (en) 2020-03-09 2021-09-16 Virtexx Methyl-cyclodextrin for use in treating enveloped virus infections such as cov-2
FR3115682B1 (fr) 2020-11-05 2023-02-24 Roquette Freres Compositions à base de méthyl-cyclodextrines pour le traitement et/ou la prévention de la stéatose hépatique
CN113529418B (zh) * 2021-06-29 2023-06-09 安徽三宝棉纺针织投资有限公司 利用有机棉制备抗菌防螨襁褓用品的工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651725B2 (ja) * 1985-02-28 1994-07-06 メルシャン株式会社 部分メチル化シクロデキストリン及びその製造方法
US4933948A (en) * 1989-05-30 1990-06-12 Eastman Kodak Company Dye laser solutions
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE19505263A1 (de) * 1995-02-16 1996-08-22 Consortium Elektrochem Ind Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten

Also Published As

Publication number Publication date
WO2001036490A2 (en) 2001-05-25
EP1272531A2 (de) 2003-01-08
CA2391008A1 (en) 2001-05-25
DE60032388T2 (de) 2008-01-10
CN1303107C (zh) 2007-03-07
CA2391008C (en) 2009-12-22
EP1272531B1 (de) 2006-12-13
EP1272531B8 (de) 2007-02-14
AU3643301A (en) 2001-05-30
US6602860B1 (en) 2003-08-05
CN1620469A (zh) 2005-05-25
WO2001036490A3 (en) 2001-11-08
EP1272531A4 (de) 2003-03-19
DE60032388D1 (de) 2007-01-25
MXPA02004743A (es) 2003-10-14
JP2003514925A (ja) 2003-04-22

Similar Documents

Publication Publication Date Title
ATE348116T1 (de) Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen
NO20074256L (no) Fremstilling av stopte legemer fra ligocellulosebaserte finpartiklete materialer
TWI255828B (en) Highly nucleated thermoplastic articles
WO2008104960A3 (en) Personal care product comprising cyclodextrin as fragrance- complexing material
WO2008104954A3 (en) Personal care product comprising cyclodextrin as fragrance-complexing material
ATE306896T1 (de) Cyclodextrin zur geruchskontrolle in deodorant- zusammensetzungen
JO2293B1 (en) Derivatives of 3-indoleil 4-phenyl-1H-birol-5.2 -Dayon as inhibitors of glycogen synthacinase-3b
MXPA05014082A (es) Acidos biariloximetilarenocarboxilicos.
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
WO2007059507A3 (en) Compositions comprising lipoxygenase inhibitors and cyclodextrin
ATE528990T1 (de) Desinfektions- und entkeimungsmittel
BR0016692A (pt) Aditivo encapsulado de liberação temporal para artigos absorventes
WO2001091738A3 (en) Naaladase inhibitors for treating amyotrophic lateral sclerosis
BG105731A (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
WO2007069217A3 (en) Absorbent products having complementary fragrances and a package for storing absorbent products
AR053559A1 (es) Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados
WO2003063824A3 (en) Pharmaceutical composition
EP1062941A3 (de) Desodorierende Mittel für Nahrungsmittel und Getränke, orale Zusammensetzungen und Toilettenartikel
MXPA01003633A (es) Precursores de fragancia.
WO2008036067A3 (en) Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
HUP0100974A2 (hu) Integrált additív készítmény, eljárás előállítására és alkalmazására
ATE539045T1 (de) Parfümierungsbestandteile des holzigen typs
WO2002009717A1 (fr) Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif
WO2005053660A3 (en) Pharmaceutical compositions comprising danazol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties